In addition, among many risk factors that may contribute to lung cancer incidence or mortality, endocrine factors including estrogen are critical modulators of lung cancer development and progression, and there is accumulating evidence that ERβ expression in conjunction with aromatase expression predicts survival in non-small cell lung cancer both in men and women (35, 36). Here, ESR2 is linked to lung cancer.